Your browser doesn't support javascript.
loading
A rapid intrapartum test for group B Streptococcus to reduce antibiotic usage in mothers with risk factors: the GBS2 cluster RCT.
Daniels, Jane; Dixon, Emily F; Gill, Alicia; Bishop, Jon; D'Amico, Maria; Ahmed, Khaled; Dodds, Julie; Tryposkiadis, Kostas; Wilks, Mark; Millar, Michael; Husain, Shahid; Gray, Jim; Whiley, Angela; Moore, Patrick V; Munetsi, Ruvimbo L; Hemming, Karla; Roberts, Tracy; Plumb, Jane; Deeks, Jonathan; Khan, Khalid S; Thangaratinam, Shakila.
Afiliação
  • Daniels J; Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, Nottingham, UK.
  • Dixon EF; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Gill A; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Bishop J; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • D'Amico M; Centre for Women's Health, Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Ahmed K; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Dodds J; Centre for Women's Health, Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Tryposkiadis K; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Wilks M; Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Millar M; Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Husain S; Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Gray J; Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Whiley A; Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Moore PV; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Munetsi RL; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Hemming K; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Roberts T; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Plumb J; Group B Strep Support, Haywards Heath, UK.
  • Deeks J; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Khan KS; Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Thangaratinam S; Institute of Metabolism and System Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Health Technol Assess ; 26(12): 1-82, 2022 02.
Article em En | MEDLINE | ID: mdl-35195519
ABSTRACT
WHAT IS THE PROBLEM?: Group B Streptococcus is a common bacterium found in the vagina and intestines of approximately one in four women. Group B Streptococcus may be passed to the baby around birth and cause severe infection. In the UK, women are offered antibiotics in labour to protect their baby from group B Streptococcus infection when specific risk factors are present. Most women with risk factors do not carry group B Streptococcus and their babies are unnecessarily exposed to antibiotics. Most women carrying group B Streptococcus do not have risk factors and so will not be offered antibiotics to protect their babies. WHAT DID WE PLAN TO DO?: We planned to find out if, for women with risk factors, a 'rapid test' in labour resulted in fewer women receiving antibiotics compared with 'usual care'. We also wanted to establish if the test correctly identified if mothers were carrying group B Streptococcus, helped reduce infections in babies and represented value for money. WHAT DID WE FIND?: We involved 1627 women (1700 babies) from 20 hospitals randomly allocated to rapid test or usual care. Using the 'rapid test' did not reduce antibiotics provided to mothers (41% in rapid test units and 36% in usual-care units). The test correctly identified 86% of women carrying group B Streptococcus, 89% of those who did not and failed to provide a result in 14% of women. A rapid test policy resulted in 13% fewer babies receiving antibiotics. The rapid test generated no cost savings when only the mothers' care was considered, but there was potential for reduced costs when including the newborns' hospital stay. WHAT DOES THIS MEAN?: The rapid test is accurate; however, using it for women with risk factors for their baby developing group B Streptococcus infection does not reduce antibiotic usage in mothers, although it does in babies. Value for money is uncertain and depends on what costs are included.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Infecções Estreptocócicas / Streptococcus agalactiae Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Health_technology_assessment / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: Health Technol Assess Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Infecções Estreptocócicas / Streptococcus agalactiae Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Health_technology_assessment / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: Health Technol Assess Ano de publicação: 2022 Tipo de documento: Article